Ipsos Healthcare Launches Syndicated Lab Mapping Study

Wednesday, November 26, 2014

New York, NY – Ipsos Healthcare, the global healthcare division of Ipsos, has announced the launch of its syndicated Lab Mapping Study in the field of Oncology Molecular Diagnostics (MDx).

The new study – which currently covers the US but will soon be rolled out in EU5, Australia and China – delivers a comprehensive picture of the laboratories involved in cancer biomarker testing.

Specifically, the data collected from Lab Directors enables subscribers to: map out the type, structure and workforce of the laboratories; capture details around testing volume and tissue flow; and break down the volume of testing carried out by cancer type and methodology of biomarker testing.

Commented Pieter De Richter, Head of Ipsos Healthcare’s Molecular Diagnostics Portfolio: “Given the complexity of this industry and the great variety of different commercial and non-commercial laboratory types, this provides an invaluable tool for companies seeking to plan and implement a companion diagnostics launch strategy.”

For more information on this news release please contact:

Pieter De Richter
Head of Molecular Diagnostics Portfolio
Ipsos Healthcare
+60 3 2297 5628
Pieter.DeRichter@ipsos.com

Ayse Levent
Vice President, Global Therapy Monitors
Ipsos Healthcare
1 646 313 7725
Ayse.Levent@ipsos.com

Joanna Butcher
Syndicated Marketing
Ipsos Healthcare
+44 (0)7818 422117
Joanna.Butcher@ipsos.com

About Ipsos Healthcare

Ipsos Healthcare is a global specialised practice focusing on research in the pharmaceutical, bio-tech and medical device markets. It is also a leading provider of global syndicated patient chart studies in 35 markets. Operating in over 40 countries, the team of 500 healthcare market research experts, marketers and client-side brand-builders focuses on delivering outcome-oriented research for its clients. Drawing from a broad range of qualitative and quantitative techniques, Ipsos Healthcare offers custom and syndicated research programmes to evaluate the motivations, experiences, interactions and influences of stakeholders forming the multi-customer markets that increasingly drive business success in the healthcare industry.

About Ipsos

Ipsos is an independent market research company controlled and managed by research professionals. Founded in France in 1975, Ipsos has grown into a worldwide research group with a strong presence in all key markets. Ipsos ranks third in the global research industry.

With offices in 86 countries, Ipsos delivers insightful expertise across six research specializations: advertising, customer loyalty, marketing, media, public affairs research, and survey management.

Ipsos researchers assess market potential and interpret market trends. They develop and build brands. They help clients build long-term relationships with their customers. They test advertising and study audience responses to various media and they measure public opinion around the globe.

Ipsos has been listed on the Paris Stock Exchange since 1999 and generated global revenues of €1,712,4 million (2 274 M$) in 2013.

Visit www.ipsos.com to learn more about Ipsos’ offerings and capabilities.


Ipsos Healthcare Launches Syndicated Lab Mapping Study

Downloads PDF

Press Release

Contact

Ayse Levent
Vice President, Global Therapy Monitors
Ipsos Healthcare
1 646 313 7725
Ayse.Levent@ipsos.com
Pieter De Richter
Head of Molecular Diagnostics Portfolio
Ipsos Healthcare
+60 3 2297 5628
pieter.derichter@ipsos.com
Joanna Butcher
Marketing and Communications Director, UK
Ipsos Mori
+44 07818 422117
joanna.butcher@ipsos.com